PROTHROMBIN G20210A

Clinical trials for PROTHROMBIN G20210A explained in plain language.

Never miss a new study

Get alerted when new PROTHROMBIN G20210A trials appear

Sign up with your email to follow new studies for PROTHROMBIN G20210A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New shot aims to prevent dangerous clots in High-Risk patients

Disease control Recruiting now

This early-stage study tests a single injection of a new drug called CITY-FXI in healthy adults and those with Factor V Leiden or prothrombin G20210A mutation, which increase blood clot risk. The goal is to see if the drug is safe and how it works in the body. About 128 participa…

Matched conditions: PROTHROMBIN G20210A

Phase: PHASE1 • Sponsor: City Therapeutics • Aim: Disease control

Last updated May 05, 2026 11:52 UTC

PROTHROMBIN G20210A

Get alerted when new PROTHROMBIN G20210A trials appear

New shot aims to prevent dangerous clots in High-Risk patients